Rituxan (rituximab) - Roche
Rasmussen-Like Asymmetric Cortical Atrophy in Anti-NMDA Receptor Encephalitis. (PubMed, Neurohospitalist) - Sep 15, 2026 - "He was treated with intravenous corticosteroids, immunoglobulin, and rituximab...The presence of milder contralateral imaging abnormalities and persistent anti-NMDA receptor seropositivity after clinical stabilization supports an atypical presentation of anti-NMDA receptor encephalitis. This case expands the literature on Rasmussen-like autoimmune encephalitis and potential overlap syndromes." 
Journal • CNS Disorders • Epilepsy • Hodgkin Lymphoma • Immunology • Insomnia • Oncology • Pain • Sleep Disorder
http://www.ncbi.nlm.nih.gov/pubmed/42733396
 
Jenny Linnoila; Otto Rapalino; Yoji Hoshina
 
Sep 15, 2026
 
Prev Next